NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $72 | -18.2% | 125 | 0.0% | 0.00% | – |
Q1 2023 | $88 | -68.8% | 125 | 0.0% | 0.00% | – |
Q4 2022 | $282 | – | 125 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 125 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 125 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 125 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | -33.3% | 125 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 125 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 125 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 125 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 125 | +66.7% | 0.00% | – |
Q1 2019 | $3,000 | +50.0% | 75 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 75 | +50.0% | 0.00% | – |
Q3 2018 | $3,000 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |